## Abstract Acylation stimulating protein (ASP) stimulates triglyceride synthesis and glucose transport via its receptor C5L2. In human studies, ASP is increased in insulin resistant states such as obesity, diabetes, polycystic ovary syndrome and late pregnancy (the latter two associated with alter
Palmitate and oleate induction of acylation stimulating protein resistance in 3T3-L1 adipocytes and preadipocytes
✍ Scribed by Yu Wen; HongWei Wang; Robin MacLaren; Jing Wu; HuiLing Lu; Katherine Cianflone
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 205 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Acylation stimulating protein (ASP) stimulates triglyceride synthesis and glucose transport via its receptor C5L2. The aims were (i) to evaluate ASP response under insulin‐resistant conditions and (ii) to identify mechanisms of ASP resistance using 3T3‐L1 adipocytes and preadipocytes. Overnight incubation with palmitate (PAL) or oleate (OLE) induced dose‐dependent inhibition of ASP‐stimulated glucose transport in adipocytes (198 ± 18% +ASP, 100 ± 4% basal, 131 ± 14% + ASP + 1 mmol/L PAL) and preadipocytes (287 ± 21% + ASP, 100 ± 4% basal, 109 ± 13% + ASP + 1 mmol/L PAL). In adipocytes, dose‐dependent maximal C5L2 mRNA decreases were −41 ± 15% and −82 ± 2%, with decreased cell‐surface C5L2 of −55 ± 12% and −39 ± 9% (1 mmol/L PAL and OLE, respectively) with no change in preadipocytes. Adipocytes treated with PAL or OLE evidenced inhibition of ASP stimulation of G proteins: Gβ (−50%), Gαq/11 (−50%) and protein kinase C: PKCα‐P (−52%), PKCζ‐P (−43%). Fatty acid‐induced ASP resistance via C5L2 may contribute to altered adipose tissue function and obesity/insulin resistance phenotype in humans. J. Cell. Biochem. 104: 391–401, 2008. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Accumulation of advanced oxidation protein products (AOPPs) is prevalent in metabolic syndromes, a condition with impaired preadipocytes differentiation. In the present study, we tested the hypothesis that AOPPs disturb preadipocyte differentiation. Exposure of 3T3‐L1 preadipocytes to i
## Abstract Several studies have demonstrated increases in acylation stimulating protein (ASP), and precursor protein C3 in obesity, diabetes and dyslipidemia, however the nature of the regulation is unknown. To evaluate chronic hormonal and pharmaceutical mediated changes in ASP and potential mech
The active metabolite of vitamin D3, 1 a,25-dihydroxyvitamin D3 (1,25(OH),D,), inhibited morphologic and enzymatic expression during differentiation of preadipocyte to adipocyte. In the presence of -6.4-20 x M 1 ,25(OH)>Di, the triacylglycerol accumulation was only 50% of that of fully differentiate
Differentiating 3T3-L1 preadipocytes (murine fatty fibroblasts) and human preadipocytes interact with human lipoprotein subfractions (HDL 2 and LDL II/III ) at all stages of the differentiation program, displaying saturable binding behavior. Both cell types interact similarly with LDL II/III as diff
Previous investigations have demonstrated that both G s -and the G i -family of GTP-binding proteins are implicated in differentiation of the 3T3-L1 preadipocyte. In order to further analyze the role of G s a vs. G i2 a, which are both involved in adenylate cyclase modulation, we transfected undiffe